332 related articles for article (PubMed ID: 22553244)
41. Clinical performance of multiplex high-risk e6 mrna expression in comparison with hpv dna subtypes for the identification of women at risk of cervical cancer.
Ho CM; Pan KY; Chen YY; Huang CY; Chen YL; Chang SF
J Med Virol; 2015 Aug; 87(8):1404-12. PubMed ID: 25940199
[TBL] [Abstract][Full Text] [Related]
42. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
43. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis.
Berkhof J; de Bruijne MC; Zielinski GD; Bulkmans NW; Rozendaal L; Snijders PJ; Verheijen RH; Meijer CJ
Int J Cancer; 2006 Apr; 118(7):1759-68. PubMed ID: 16217759
[TBL] [Abstract][Full Text] [Related]
45. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
J Clin Virol; 2012 May; 54(1):61-5. PubMed ID: 22326759
[TBL] [Abstract][Full Text] [Related]
46. Relationship between HPV 16, 18, 31, 33, 45 DNA detection and quantitation and E6/E7 mRNA detection among a series of cervical specimens with various degrees of histological lesions.
Baron C; Henry M; Tamalet C; Villeret J; Richet H; Carcopino X
J Med Virol; 2015 Aug; 87(8):1389-96. PubMed ID: 25908062
[TBL] [Abstract][Full Text] [Related]
47. Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology.
Sørbye SW; Arbyn M; Fismen S; Gutteberg TJ; Mortensen ES
PLoS One; 2011; 6(8):e24083. PubMed ID: 21918682
[TBL] [Abstract][Full Text] [Related]
48. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
Wang HY; Kim H; Park KH
Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
[TBL] [Abstract][Full Text] [Related]
50. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women.
Bulkmans NW; Rozendaal L; Snijders PJ; Voorhorst FJ; Boeke AJ; Zandwijken GR; van Kemenade FJ; Verheijen RH; v Groningen K; Boon ME; Keuning HJ; van Ballegooijen M; van den Brule AJ; Meijer CJ
Int J Cancer; 2004 May; 110(1):94-101. PubMed ID: 15054873
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study.
Reid JL; Wright TC; Stoler MH; Cuzick J; Castle PE; Dockter J; Getman D; Giachetti C
Am J Clin Pathol; 2015 Sep; 144(3):473-83. PubMed ID: 26276778
[TBL] [Abstract][Full Text] [Related]
52. MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer.
Basu P; Chandna P; Bamezai RN; Siddiqi M; Saranath D; Lear A; Ratnam S
J Clin Microbiol; 2011 Oct; 49(10):3537-44. PubMed ID: 21813716
[TBL] [Abstract][Full Text] [Related]
53. Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study.
Castle PE; Cuzick J; Stoler MH; Wright TC; Reid JL; Dockter J; Giachetti C; Getman D
Am J Clin Pathol; 2015 Feb; 143(2):160-7. PubMed ID: 25596241
[TBL] [Abstract][Full Text] [Related]
54. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
[TBL] [Abstract][Full Text] [Related]
55. Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia.
Rohner E; Rahangdale L; Sanusi B; Knittel AK; Vaughan L; Chesko K; Faherty B; Tulenko SE; Schmitt JW; Romocki LS; Sivaraman V; Nelson JAE; Smith JS
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896666
[TBL] [Abstract][Full Text] [Related]
56. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
57. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?
van der Marel J; Berkhof J; Ordi J; Torné A; Del Pino M; van Baars R; Schiffman M; Wentzensen N; Jenkins D; Quint WG
Am J Surg Pathol; 2015 Apr; 39(4):496-504. PubMed ID: 25353286
[TBL] [Abstract][Full Text] [Related]
58. HPV mRNA testing in triage of women with ASC-US cytology may reduce the time for CIN2+diagnosis compared with repeat cytology.
Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
Curr Pharm Des; 2013; 19(8):1401-5. PubMed ID: 23016772
[TBL] [Abstract][Full Text] [Related]
59. Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women.
Granados R; Tellez-Safina H; Solis I; Mateos F; Rodriguez-Barbero JM; Aramburu JA; Huertas MA; Bajo P; Camarmo E; Corrales T; Medina P; Calvo B; Martin E; Anta L; Zamora M; Alcaide T
Diagn Cytopathol; 2017 Dec; 45(12):1065-1072. PubMed ID: 28949442
[TBL] [Abstract][Full Text] [Related]
60. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
Dong L; Wang MZ; Zhao XL; Feng RM; Hu SY; Zhang Q; Smith JS; Qiao YL; Zhao FH
Gynecol Oncol; 2018 Jan; 148(1):103-110. PubMed ID: 29169614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
